Caregiver Stress and Sleep Study
University of Pittsburgh · with National Institute of Mental Health (NIMH) · NCT05219955
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 55+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- July 15, 2022
- Record last updated
- May 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to better understand how stress, sleep and activity might impact caregivers' mood and brain health. This study includes a randomized experimental component where therapists will systematically deliver one of two evidence-based talk-therapy treatments. The aim is to evaluate effects on meaningful health-relevant measures including morning activation levels, depression symptoms, rumination, and aspects brain connectivity previously linked with depression. Participants will complete surveys about their caregiving experiences, health, and mood, undergo an MRI, and wear an actigraphy watch that measures activity levels throughout the day and when sleeping.
Being studied: Morning Action Plan Execution; Activity Strategy-based Session with Therapist; Attention-based Session with Therapist; Advance sleep-wake time
Conditions: Depressive Symptoms; Caregiver Burden
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 55 years or older.
- Provide at least 15 hours/week of unpaid care to a patient with a dementia diagnosis.
- Reporting stress or strain delivering care
- No or stable pharmacotherapy for depression
- Meets screening definition for having morning activation difficulty or a definite morning type per the Composite Morningness Questionnaire (CMQ)
Exclusion Criteria
- Unsafe or unable to undergo MRI
- Active Cognitive Behavioral Therapy for mood or insomnia
- Probable dementia diagnosis
- Deadly illness or plans to leave the study area
- Current active substance use disorder
Recruiting US locations
UPMC Western Behavioral Health
Pittsburgh, PA 15213
Site contact: Sara Sellars, MA · 412-246-5963 · alberts3@upmc.edu
Study contacts (from the official record)
- Sara Sellars, MA · 412-246-5963 · alberts3@upmc.edu
Similar studies in Pennsylvania
All sleep studies in Pennsylvania →- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Abington, PA + 32 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Alkermes, Inc.
- Location
- Wyomissing, PA + 21 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Alkermes, Inc.
- Location
- Wyomissing, PA + 21 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Janssen Research & Development, LLC
- Location
- Philadelphia, PA + 41 other US sites
- Eligibility basics
- Ages 18–74